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) . In addition, others (19, 20) have demonstrated production of some helper factors distinct from IL-2 that facilitate the development of cytotoxic cells, but have failed to demonstrate the production of a significant amount of IL-2 in the murine SMLR.
We (21) have recently demonstrated that the murine SMLR that uses responder T cells and stimulator non-T cells, which were prepared and cultured in the absence of any xenogeneic protein stimulation, induces a significant proliferative response and produces a hematopoietic growth regulator, interleukin 3 (IL-3), but not IL-2. These studies have also demonstrated that the murine SMLR may be primarily a cell interaction, in which the non-T cells stimulate helper T cells to produce IL-3, which in turn induces proliferation of IL-3-responding cells, but not mature T cells, that appear to have a phenotype of relatively early precursors in lymphocyte differentiation .
The purpose of this study was to carefully analyze the human AMLR, particularly examining whether the proliferative response in the AMLR system can be induced by using cell separation methods and culture in the absence of xenoantigens, and what kinds of soluble factors regulating the reaction are produced. The results provide evidence that AMLR in the absence of any added foreign antigens generates no IL-2 production, but does generate production of a cytokine with murine IL-3-like properties, which mediates cell proliferation in the reaction.
Materials and Methods
Preparation ofResponder and Stimulator Cells in AMLR. Mononuclear cells were isolated from the venous blood of healthy normal volunteers by Ficoll-Isopaque gradient centrifugation, as described (22) , except that autologous human serum (AHS), was used instead of FCS in making the Ficoll-Isopaque gradient . The separated mononuclear cells were washed three times with RPMI 1640 medium (Gibco Laboratories, Grand Island, NY) and were suspended with culture medium containing 20% AHS (RPMI/AHS) .
To separate nonadherent responder T cells and adherent stimulator cells, a 20-ml glass syringe was packed with 5 g nylon wool (NY) (Leuko-Pak leukocyte filter, Travenol Laboratories, IL), drained with RPMI/AHS, and equilibrated in a 37°C incubator for 60 min. To this column, 1-3 X 108 mononuclear cells in 2-4 ml of RPMI/AHS medium were added drop by drop. The column was then washed with an additional 1 ml of warm medium. The column was then incubated at 37°C for 60 min in a 5% CO2/95% air humidified atmosphere . The nonadherent cells were eluted with 40-60 ml of warm RPMI/AHS media at a flow rate of one drop per second, and used as responder cells (23) . Responder cell fractions thus obtained contained >82% T cells as determined by the reaction with T3 monoclonal antibody and a FACS analyzer (Becton, Dickinson & Co., Sunnyvale, CA), and <0.4% B cells as detected by surface immunoglobulins .
To obtain stimulator cells, NY-adherent cells were recovered by transferring the NY wool to a Petri dish containing AHS-free RPMI 1640 medium and teasing it apart with forceps . The cells collected in the centrifuge tube were then spun for 10 min at 200 g and suspended in the RPMI/AHS medium . The cells were treated with mitomycin C (MMC) at 25 tug/10' cells for 60 min at 37°C and then used as stimulator cells . These non-T cell fractions contained^-60% surface Ig+ B cells, 15-25% monocytes, and <8% T lymphocytes, the rest being non-T, non-B cells .
Cultured Conditions for AMLR . RPM I 1640 medium was supplemented with 20% heatinactivated (56°C, 45 min) fresh AHS . In addition, culture medium contained 80 MM Lglutamine (Sigma Chemical Co., St. Louis, MO) and 5 X 10-5 M 2-mercaptoethanol . These conditions were used throughout the experiments except where otherwise stated . To obtain the culture supernatants for interleukin and interferon (IFN) assays, 2.5 X 106 responder T cells plus 2 .5 X 106 MMC-treated stimulator cells were incubated in 24-well flat-bottomed culture plates (Nunc, Roskilde, Denmark) with a total volume of 2.0 ml . Cells and supernatants were recovered by centrifugation at 200 g for 10 min. The supernatants were passed through 0.2-jm filters (Millipore Corp., Bedford, MA), and then tested for IL-2, IL-3, and IFN activities .
For determination of DNA replication, 200 wl of the cell suspensions were cultured in 96-well round-bottomed microtiter plates (Falcon Labware, Oxnard, CA) at 37°C. 18 h before harvest, 0.5 ACi oftritiated thymidine (specific activity, 5 Ci/mmol; the Radiochemical Centre, Amersham, England) was added to each well, and the amount of radioactive uptake was measured. Data are expressed as the mean counts per minute and standard deviation of triplicate cultures.
Allogeneic MLR Assays. Allogeneic MLR was tested by using NY-nonadherent responder cells from a donor and MMC-treated NY-adherent stimulator cells from another allogeneic donor, both of which were prepared as described above. Fresh autologous serum from a responder donor, but not FCS was used for the cell separation medium . The cultured cells and their supernatants were also obtained as described in AMLR.
Assays for IL-3 Activity. The assay for IL-3-like activity was performed as previously described with the murine IL-3-dependent cell line, 32Dcl (24) (25) (26) . Briefly 104 32Dcl cells were cultured in a final volume of 200 Al in the presence of several concentrations of material being tested for IL-3 activity. After 21-24 h of culture at 37°C, each culture was pulsed overnight with 0.5 uCi of ['H]TdR, harvested onto glass fiber filters, and counted for radioactive thymidine uptake. The results are expressed as the mean and standard deviation (SD) of specific ['H]TdR incorporation (cpm) in triplicate cultures, as described (26) .
Mouse IL-3 was purifed from WEHI-3 culture supernatants by DEAE cellulose chromatography followed by chromatography on Sephacryl S-200 column and a reverse-phase high-performance liquid chromatographic system, as previously described (26) . This partially purified IL-3 had a specific activity of 1 .2 ng/U measured by proliferation of 32Dcl cells, and was used as a standard preparation for IL-3 activity.
IL-2 and IL-2 Assays. Human recombinant IL-2 (rIL-2) with a specific activity of 1 .0 X 10' U/mg (27) was supplied by Shionogi Pharmaceutical Co., Ltd . (Osaka, Japan) and used as a standard IL-2. The IL-2-dependent NK cell line NK-7 (27, 28) used in routine assays for the detection of IL-2 activity was maintained in RPMI 1640 containing 10% FCS and 50 U/ml of rIL-2 . Another IL-2-dependent T cell line, CTLL-2 (29), was used for some experiments and maintained in RPMI 1640/10% FCS plus 1 % sodium pyruvate and 50 U/ml of rIL-2 .
Using these cell lines, the assays of IL-2 activity were carried out as previously described (30) . Results are expressed as the mean and SD of specific ['H]TdR incorporation (cpm) in triplicate cultures, as described (30) . The data are then expressed in units (U) by comparing experimental probit data with that obtained with the use of a standard rIL-2 preparation . 1 U of a standard IL-2 is the concentration necessary to stimulate 50% of the maximum ['H]TdR uptake by NK-7 cells (30) . IL-2 levels of 0 .05 U/ml or greater are significant by probit analysis. Murine monoclonal antibody against human rIL-2 was supplied by Shionogi Pharmaceutical Co. Ltd . One unit of anti-rIL-2 was defined as the dose required to neutralize one unit of rIL-2 (Yoshida et al., manuscript in preparation) .
IFN-y, anti-IFN-y Serum, and IFN Assay. Human recombinant IFN-y with a specific activity of 1 .0 X 10' U/mg and monoclonal antibody against recombinant human INF-y (27) were kindly supplied by Shionogi Pharmaceutical Co. The 1:10,000 antiserum neutralized natural and recombinant human IFN-y at 10 U/ml, but the antiserum, even undiluted, could not neutralize human recombinant IFN-a or IFN-,B at 10 U/ml. Antiviral activity was assayed on human WISH cells by the 50% plaque reduction method and expressed as reciprocal values of the dilutions that reduce the numbers of virus plaques by 50%, as previously described (21) .
Monoclonal Reagents . Monoclonal antibodies ofthe OK series, i.e., OKT3 (anti-panT), OKT4 (anti-helper/inducer T), and OKT8 (anti-suppressor/cytotoxic T), were purchased from Ortho Diagnostics (Raritan, NJ) . Cells reactive with these antibodies were enumerated by an indirect immunofluorescence and FACS. A monoclonal antibody to HLA-DR antigens (OKIal) was purchased from Ortho Diagnostics . This antibody is directed against the complex of both chains of DR antigens and it binds to B cells and macrophages but not to normal T cells .
Elimination of OKT4 or OKT8 Cell Population by Complement-mediated Lysis. Lysis of T cell populations by monoclonal antibodies was done as previously described (31) with a minor modification . Briefly, test cells were treated wtih 0.1 ml of OKT4 or OKT8 antibody (100 )Ag of protein/ml) and 1 .0 ml of 1 :10-diluted rabbit C (Lo-Tox-H rabbit complement, Cederlane Laboratories, Ltd ., Hornby, Ontario, Canada) in RPMl/AHS for 45 min at 37°C. The surviving cells were then washed three times, counted, and tested for their response to AMLR stimulators. When T cell-enriched responder fractions were treated with anti-T4 and C, residual cells consisted of>90% T3+ and T8+ cells, with <2% T4+ cells. Treatment of cells with anti-T8 and C yielded preparations consisting of>90% T3+ and T4+ cells and <3% T8+ cells .
General Biochemical Procedures. Protein determinations throughout the purification employed were based on the OD at 280 nm. The AMLR culture fluids were condensed by ultracentrifugation using the Diaflow membrane YM-5 (Amicon Corp., Lexington, MA). Gel filtration analysis of these condensed AMLR culture fluids was performed by using a Superose 12 column of the fast protein liquid chromatography (FPLC) system (Pharmacia Fine Chemicals, Uppsala, Sweden) . DEAE cellulose chromatography was done by using a MonoQ column of the FPLC system (Pharmacia Fine Chemicals). For both chromatographies, the condensed AMLR culture fluids were dialyzed extensively against equilibration buffer, and applied to the column . The Superose 12 column was equilibrated and developed with 10 mM phosphate-buffered saline (PBS, pH, 7 .2), and 0.5 ml of effluents at each fraction were collected and then assayed for cell growth-stimulating activities. The M,. ofthe activities in this gel filtration were calibrated by using the standard markers, ferritin (M, 440,000), aldolase (M r 158,000), bovine serum albumin (Mr 67,000), and ribonuclease A (M, 13,700) . The MonoQ column was eluted with a linear gradient of 0-0.5 M NaCl. Fractions of 0.5 ml were collected and the biological activities of each were determined .
Bone Marrow Cultures. Bone marrow was obtained from healthy volunteers by aspiration from the iliac crest . Light-density cells were separated by Ficoll-Isopaque density gradient centrifugation . Cells were washed with the buffer and suspended at 5 X 106 cells/ml in RPMI 1640 medium containing 10% FCS . To 100 /1 ofcell suspensions seeded in wells of a 96-well microtiter plate (Falcon Labware) was added 100 Al of test materials at twofold dilutions and then incubated at 37°C for 72 h. Cultures were harvested onto glass fiber filter papers and counted by the liquid scintillation technique for thymidine incorporation as described .
Results DNA Replication in AMLR in the Absence ofForeign Proteins. Table I Inhibition of the AMLR Response by Monoclonal Anti-DR Antibody. It has been reported that in the SMLR or AMLR, as well as the allogeneic (alto) MLR, the class II major histocompatibility complex (MHC) gene products (ta or HLA-DR antigens) are critically important in stimulating this response (8, 9, 13, 14) . It has also been shown that the responder cells in human AMLR are T4 +,T8-helper/inducer type of T cells (32, 33) . We therefore examined whether the AMLR induced in our systems also involves an interaction between the HLA-DR+ stimulator cells and responder/helper T cells, by using monoclonal antibodies. As shown in Table 11 , when the responder T cells were incubated with autologous or allogeneic stimulator cells in the presence of anti-DR monoclonal antibody, the proliferative response in AMLR, as well as in alto-MLR, was significantly inhibited by the antibody in a dose-related fashion.
Subsequently, nonadherent T cells were treated with complement and T4 or T8 monoclonal antibody, and examined for DNA replication in response to autologous stimulator adherent cells (Table III) . Nonadherent T cells that had been depleted of T4 but not of T8 cells produced an extremely reduced DNA The C-treated, or C plus anti-OKT4-or OKT8-treated nonadherent T cells were reconstituted to 10' lymphocytes/ml, and used as responder cells in AMLR.
[sH]TdR incorporation was measured on day 5 of culture. * Each value is the mean ± standard deviation of three cultures . $ Percent inhibition of medium control.
replication, indicating that the T4'T8 -helper/inducer T cells are involved in DNA replication in AMLR as previously described (31, 32) .
Production of a Lymphokine with IL-3-like Properties but Not IL-2 or IFN in AMLR. We next examined, in addition to DNA replications, production of IL-2 and IFN, and the murine IL-3-like activity assayed by 32Dcl cell line, in the AMLR supernatants of the coculture of responder T cells with stimulator non-T cells in a culture medium containing AHS. These results were compared with those for allo-MLR, in which the responder T cells from the same donor were incubated with the stimulator cells isolated from another donor . The results of a representative experiment shown in Fig . 1 A indicate that DNA replication in AMLR was demonstrable on day 3 after incubation, and reached a peak on day 5, decreasing thereafter. Regardless of this active proliferative response, no minimal levels of IL-2 (0 .05 U/ml) and IFN (2 U/ml) could be detected during the entire culture periods, but the activity stimulating the growth of a murine IL-3-dependent cell line 32Dc1 was found . The activity to a minimal level was detected as early as 1 d after incubation in AMLR, increased with time, and reached the maximum (18 X IOs cpm) on day 5. On the other hand, in alloMLR ( Fig. 1 B) , IL-2 at^-10 U/ml and IFN at 80 U/ml could be induced . Production of the activity that stimulated 32Dcl cells with a maximum of 5 X 10s cpm on day 5 was also induced .
To confirm that there was no production of IL-2 in the AMLR, the AMLR supernatants on day 3 were condensed into a 0 .1 vol by a Centricon membrane and tested for IL-2 activity in their serial dilutions using CTLL-2 and NK-7 cell lines, and for activity stimulating the murine IL-3-dependent cell line 32Dcl (Fig. 2) . The human rIL-2 served as controls (Fig. 2) . The condensed culture fluids were found to contain an increased amount of murine IL-3-like activity stimulating the target, but no IL-2 assessed by either CTLL-2 or NK-7, both of which were responsible for rIL-2 stimulation . With the culture fluids harvested on day 1, 2, or 4, no IL-2 activity was detected . Also, no IFN activity was found in any condensed AMLR culture fluids (data not shown) .
No Involvement ofIL-2 and IFN-y in DNA Replication in the AMLR. We further examined whether IL-2 and IFN, which might be produced in the AMLR to undetectable levels, are involved in the development of DNA replication in AMLR . Specific monoclonal antibodies directed against human rIL-2 or human rIFN-y were added to the culture, and then tested for their effect on the proliferative response . The cultures of a11oMLR in the presence of anti-IL-2 or anti-IFN-y served as controls (Table IV) . The results clearly showed that both 2 .5-10 U/ml of anti-rIL-2 and 25-50 U/ml of anti-rIFN-y did not affect the proliferative response of AMLR, whereas they definitely diminished the proliferation of cells in the allo-MLR in a dose-related fashion. These results indicate that DNA replication in AMLR, unlike allo-MLR, did not involve either IL-2 or IFN --y in the reaction .
IL-3-like Activity as a Growth Factor Responsible for AMLR . We further examined whether the IL-3-like activity produced in the AMLR culture fluids is a growth factor responsible for the AMLR-induced DNA replication, which was found to be independent of IL-2 and IFN . First, we harvested the AMLR culture (Table V) . The nonadherent fraction, and unfractionated cells to a lesser extent, but not adherent mononuclear cells, responded to the AMLR culture fluids with proliferation.
Next, the AMLR culture fluids on day 5 were condensed and subjected to chromatography on FPLC-Superose 12 . The effluents were tested for activity supporting the proliferation of 32Dcl and activity inducing the proliferation of nonadherent responder cells (Fig . 3) . The results show that both activities were eluted from the column as a single peak at fraction 31 (corresponding to an Mr of 15,000-28,000) . Neither IL-2 nor IFN was found in any effluents of AMLR culture fluids from the column (data not shown) .
The AMLR culture fluids concentrated by an Amicon membrane were also applied to a chromatography on a MonoQ column of the DEAE-type FPLC system . The column was subsequently eluted with a linear concentration gradient of NaCI . As shown in Fig. 4 , a major factor that induces proliferation of 32Dcl did not bind to the column and was eluted in the run-through fractions. The major activity inducing the replication of AMLR responder cells was eluted together with the IL-3-like activity . Both activities inducing the growth of 32Dc1, and nonadherent responder cells were also eluted as a minute fraction from the column by 0.2-0 .3 M NaCl . Both fractions had no apparent effect on the proliferation of IL-2-responding CTLL-2 or NK-7 cells. The mitogenic tests for murine thymocytes revealed that the factors had no IL-1-like mitogenic activity (34 and data not shown) .
Furthermore, we examined whether the IL-3-like factor acted to support replication of the growing cells in the AMLR . The cells in AMLR on day 5 were rigorously washed with the buffer, incubated further for 2 d in the FPLCMonoQ column-purified factor, and then examined for the factor-dependent growth of test cells (Table VI) . The results clearly showed that the cells during AMLR culture continued to extensively grow in the medium containing the factor in a dose-dependent fashion, although they also replicated to a much lesser extent in the fresh medium without addition of the factor .
Growth-stimulating Effect of the Factor on Bone Marrow Cells. Finally, we examined whether this IL-3-like factor had any effect on stimulation of the bone marrow cell, as did the murine IL-3 (35) . The bone marrow cells isolated from a healthy donor were incubated with a medium containing factor, partially purified by MonoQ column chromatography, in a serial dilution for 60 h, and then examined for their proliferative responses (Fig. 5) . The results clearly showed that the factor, in a dose-related fashion, stimulated bone marrow cell proliferation. It was also shown that the proliferative response of bone marrow cells to the factor was much higher than that of peripheral blood lymphocytes, as was the response of murine bone marrow cells to the murine IL-3 (35) . The experiments were repeated with bone marrow cells from five other donors with similar results.
Discussion in the present study, we initially focused attention on the protection of AMLR from the sensitization of test cells by xenogeneic antigen stimulation . The problem of FCS as mitogen and antigen has been well recognized for a long time . FCS induces blastogenic and cytotoxic responses in unseparated human peripheral blood lymphocytes (PBL) (36) . SRBC, which have generally been used for separation of T and B cells, can also stimulate an antigen-specific plaqueforming cell (PFC) response in unseparated PBL in the absence of any nonspecific stimulating agent (37) . Therefore, in our experiments we used the technique of passage through NY column to separate responder T cells and stimulator non-T cells. Autologous human serum, but not FCS or allogeneic human serum, was always used for the cell separation and culture. By using these techniques, we have shown that NY-nonadherent responder cells generated a significant DNA replication in response to NY-adherent stimulator cells, without any background proliferative response in the absence of stimulator cells. Earlier studies by Huber et al. (10) and Kagan and Choi (11) reported that, in the absence of stimulation by SRBC or FCS, the human AMLR did not take place, according to the criteria of T cell proliferation . The response could be observed only in cultures that had either been supplemented with FCS or contained lymphocytes that had been previously exposed to FCS or SRBC . A more recent study by Naides et al, (38) has, however, shown that nonadherent T cell populations purified by nylon filtration or plastic adherence produce an AMLR even in the absence of exposure to xenoantigens . Although the reasons for the discrepancies among these studies, including ours, remain unknown, it is possible that the differences in the culture conditions or cell populations used might cause these discrepancies. For example, the NY-adherent non-T cells that we used as a stimulator were the same as those used by Kagan and Choi (11), but responder cells used in the study by Naides et al. (38) , as well as in our study, were NY-purified nonadherent cells, which were different from the unseparated peripheral mononuclear cells used by Kagan and Choi.
Concentrations of AMLR-IL
The AMLR assayed in the absence of xenoantigen stimulation in the present study, as well as allo-MLR, was shown to be dependent on the expression of DR antigens and mediated by T4',T8-helper/inducer T cells. These results are consistent with previous reports by other investigators showing that the human AMLR (7, 9, 32, 33) or murine SMLR (5, 8, 14) may represent helper/inducer T cell activation mediated through a receptor for self-la antigens . The AMLR in our study, however, regardless of the significant DR antigen-dependent response of helper T cells, generated no production of IL-2, in contrast to definite levels of IL-2 production in allo-MLR . Earlier studies by Palacios and Moller (15) demonstrated the production of IL-2 in an AMLR that contained lymphocytes that had been separated by rosetting using SRBC. Exposure of lymphocytes to SRBC alone stimulates significant T cell proliferation and PFC responses in the human AMLR (11) . Therefore, it is not surprising that under such conditions, IL-2 production takes place. In the murine syngeneic MLR system, Lattime et al. (17, 18) reported that T cell proliferation could be detected in cultures containing FCS but not in those supplemented with syngeneic mouse serum. However, small amounts of IL-2 were produced independent of the presence of FCS. Some other reports on human autologous (11) and murine syngeneic (19, 20) MLR have, however, failed to demonstrate the production of IL-2. Our recent work (21) has shown that the murine syngeneic MLR, as well as the human AMLR shown in the present study, generated no IL-2 production, regardless of a significant DNA replication in the absence of any xenogeneic protein stimulation.
We showed further that DNA replication induced in the human AMLR was not inhibited by addition of a specific antiserum against human rIL-2, which could suppress DNA replication in the allo-MLR . Specific IFN--Y antiserum, which was shown to suppress the allo-MLR, as described in the murine systems (39), also did not affect the human AMLR. These results may also support the results showing no production of IL-2 and IFN-y in the AMLR .
In the present study, we have found that a cytokine, which can stimulate the murine IL-3-dependent cell line 32Dc1, is produced in the AMLR soon after culture and before the onset of proliferative response . The major activity in the AMLR culture fluids had an M, of 15,000-28,000 in gel filtration, which was similar to an M, of human IL-2 (40), but it had no activity to stimulate IL-2-dependent cell lines NK-7 or CTLL-2 . The major activity did not bind to FPLCMonoQ column (DEAE type), to which IL-2 bound (40), and was recovered in the run-through fractions, as was the murine IL-3 (26, 35) . It was also found that the AMLR culture fluids contained a soluble factor that could stimulate proliferation of the fresh nonadherent mononuclear cells. The factor, when applied to the Superose 12 and FPLC-MonoQ columns was eluted from both columns together with the IL-3-like activity . These results strongly suggest that the factor may be a major activity responsible for the cell proliferation in the AMLR .
Murine IL-3 is a multilineage hematopoietic growth regulator that initiates the proliferation and differentiation of multipotential stem cells, leading to the production of all the major blood cell types (35, (41) (42) (43) . It is produced by mitogen-or antigen-activated T lymphocytes and by a number of continuous cell lines (35) . Purified murine IL-3 exhibited a growth-supporting effect on IL-3-dependent myelomonocytic, lymphoid, or mast cell lines but not on any IL-2-dependent cell lines. IL-3 derived from the WEHI-3 cell cultures has been purified to homogeneity by a combined method using different kinds of chromatography (43) . The protein is glycosylated and the Mr of the major glycosylated species was estimated to be 28,000 (43) . Recently, cDNA clones specifying the IL-3 derived from the WEHI-3 cells have been isolated, and a polypeptide of 166 amino acids, including a putative signal peptide, has been deduced from the cDNA (44) . At present, molecules equivalent to murine IL-3 have not been isolated from the human lymphocyte cultures . The factor found in the human AMLR culture fluids in this study had a murine IL-3-like property in the activity supporting the growth of murine IL-3-dependent cell line, 32Dcl, but not in that supporting the growth of IL-2-dependent cell lines NK-7 or CTLL-2 . It had no IL-2 or IFN activity . Nor was there any IL-1 activity in the factor . The factor strongly stimulated freshly isolated bone marrow cells, as did the murine IL-3 (35, 41, 42) . Although human and murine colony stimulating factors (CSF), as well as murine IL-3, could stimulate bone marrow cells (45, 46) , 32Dc1 cells responsible for murine IL-3 and the IL-3-like factor in the present study did not respond to human recombinant granulocyte/macrophage CSF (data not shown) . Some physicochemical properties, such as elution patterns in DEAE chromatography, were similar to those of murine IL-3 (42, 43) . These results strongly suggest that the factor found in this study may be a human molecule(s) equivalent to murine IL-3 or a molecule closely related to it. A similar activity was found in the allo-MLR culture fluids ( Fig. 1 ) and other antigen-specific lymphocyte cultures (data not shown) . Further purification and the physicochemical properties of the factors are being examined .
In our recent experiments (21) , it has been shown that in the murine SMLR, Thy-1 +, Lyt-1 +,2-helper/inducer T cells produce IL-3 in response to NYadherent stimulator cells, and that the IL-3 induces proliferation of Thy-1-, Lyt-1 -,2-, sIg, asialo GMI-negative cells, but not of IL-2-responsive Thy-1 + or asialo GM I-positive cells. These results suggest that the murine SMLR may be primarily a proliferative reaction to the IL-3 of early precursors in lymphocyte or hematopoietic cell differentiation . Although further experiments are underway that will determine the responder cells to the factor and proliferating cells in the human AMLR, our unpublished observations indicate that although the producing cells of IL-3 in response to the IL-3-like factor are T3', T4+, T8-, T 11' helper cells, the responding cells to the factor appear to be cells with low density but lacking a typical phenotype of T cells or NK cells (Suzuki et al., manuscript in preparation) . Therefore, we propose that the AMLR (SMLR) in human and murine systems may be a phenomenon, in which self-la antigens on the stimulator cells stimulate helper/inducer T cells to produce IL-3 or IL-3-related molecules but not IL-2, which in turn induce proliferation of the responding cells to the factor . These responding cells are not IL-2-responsive mature T cells or NK cells.
It remains unknown whether the AMLR and the selective production of IL-3 or IL-3-like molecules have a physiologic significance in regulation of normal immune responses in vivo . As to a possible role in lymphocyte differentiation, however, IL-3 has been shown to stimulate early events in the differentiation of T cells such as Thy-1 expression on the cell (35) or to augment the primary cytolytic T lymphocyte response to allogeneic tumor cells (47) . It is presumed, therefore, that the AMLR may play a role at least in T and B lymphocyte differentiation in the immune responses, acting through production of IL-3 . IL-3 has also been shown to stimulate premature B cells to produce Ig (48) .
It has also been reported by several investigators that the human or murine AM LR produces soluble factors (19, 20, (49) (50) (51) that were shown to play a helper or suppressor role in regulation of certain immune responses. Some structural homologies among certain of these factors and the IL-3-like factor found in the present study might be anticipated, although further elucidation will require additional biological and biochemical analysis .
Summary
The autologous mixed lymphocyte reaction (AMLR) was assayed in a medium containing fresh autologous serum, by using nylon-adherent stimulator cells and nonadherent responder T cells, which were prepared from human peripheral blood mononuclear cells in the absence of fetal calf serum (FCS) to avoid any sensitization to xenogeneic protein antigens . DNA replication without a background proliferative response was induced by stimulator cells in the responder cells. The addition of monoclonal anti-HLA-DR antibody to the culture or treatment of the responder cells with complement plus anti-T4 but not anti-T8 monoclonal antibody suppressed the AMLR, suggesting that this specific AMLR involves an interaction between HLA-DR antigens and helper/inducer T cells. Regardless of this specific DNA replication, the AMLR generated no production of interleukin 2 (IL-2) and interferon y (IFN-y), both of which could be found in the allogeneic (allo) MLR. In addition, DNA replication in the AMLR was not inhibited by the addition of specific antisera for IL-2 and IFN-y, both of which significantly inhibited the DNA replication in allo-MLR .
The AMLR was accompanied by production of a soluble factor, which could stimulate the proliferation of murine interleukin 3 (IL-3)-dependent cell line 32Dcl but not the proliferation of IL-2-dependent cell lines. This factor was also found to be responsible for proliferation of responder nonadherent cells in the AMLR . It strongly stimulated bone marrow cells, as did the murine IL-3 . The factor had an Mr range, as determined by gel filtration, of 15,000-28,000, but it did not bind to fast protein liquid chromatography (FPLC)-MonoQ column . Thus, the factor is distinguishable from IL-2 in physicochemical or biological properties, but similar to murine IL-3 . These results suggest that the human AMLR may be primarily a phenomenon in which non-T cells mediated by the HLA-DR antigens on the cell stimulate helper/inducer T cells to produce a lymphokine with IL-3-like properties, but no IL-2, which in turn stimulates the factor-dependent cells to proliferate .
